As of January 22, 2025, Oramed Pharmaceuticals (ORMP) has a market cap of $93.121 million USD. According to our data, Oramed Pharmaceuticals is ranked No.7740 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $93.12 M |
-4.55%
|
Dec 31, 2024 | $97.56 M |
4.76%
|
Dec 29, 2023 | $93.12 M |
-80.80%
|
Dec 30, 2022 | $0.48 B |
-15.76%
|
Dec 31, 2021 | $0.58 B |
236.79%
|
Dec 31, 2020 | $0.17 B |
-17.67%
|
Dec 31, 2019 | $0.21 B |
71.67%
|
Dec 31, 2018 | $0.12 B |
-66.67%
|
Dec 29, 2017 | $0.36 B |
47.06%
|
Dec 30, 2016 | $0.25 B |
-28.42%
|
Dec 31, 2015 | $0.34 B |
87.50%
|
Dec 31, 2014 | $0.18 B |
-70.45%
|
Dec 31, 2013 | $0.62 B |
289.65%
|
Dec 31, 2012 | $0.16 B |
17.86%
|
Dec 30, 2011 | $0.14 B |
-6.67%
|
Dec 31, 2010 | $0.15 B |
-33.33%
|
Dec 31, 2009 | $0.22 B |
15.38%
|
Dec 31, 2008 | $0.19 B |
50.00%
|
Dec 31, 2007 | $0.13 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Novo Nordisk
NVO
|
$335.24 B |
64.098 B
|
Denmark
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Market Cap | = | ORMP Stock Price | * | ORMP Shares Outstanding |
= | $2.31 | * | 40.31 M | |
= | $93.12 M |